Scarce data related to the drug survival of biologic agents in psoriasis patients aged ≥65 years is available.
No takes yet. Share an insight, caveat, or question.
Chiricozzi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: